Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/5535
Title: Pneumothorax as a Poor Prognostic Indicator in COVID-19 in Turkey: A Propensity Score Matching Analysis
Authors: Özgel, M.
Gülçek, I.
Aǧar, M.
Ulutaş, H.
Keywords: COVID-19; pneumothorax; prognostic factors; survival
Adult; Aged; Comorbidity; COVID-19; Female; Humans; Male; Middle Aged; Pneumothorax; Prevalence; Prognosis; Propensity Score; Respiration, Artificial; Retrospective Studies; Risk Factors; SARS-CoV-2; Turkey; adult; aged; artificial ventilation; comorbidity; complication; coronavirus disease 2019; epidemiology; female; human; male; middle aged; mortality; pneumothorax; prevalence; prognosis; propensity score; retrospective study; risk factor; Severe acute respiratory syndrome coronavirus 2; turkey (bird)
Publisher: Wolters Kluwer Medknow Publications
Abstract: Background: Spontaneous pneumothorax in COVID-19 occurs infrequently but in up to 15% of patients dependent on mechanical ventilation (MV). Pneumothorax-related deaths account for 1% of all COVID-19-related deaths. Aim: To determine factors associated with pneumothorax in COVID-19 patients and the effect of pneumothorax on early survival. Methods: This was a retrospective study of 4799 COVID-19-positive hospitalized patients. The groups were homogenized using propensity score matching (PSM) in two groups comprising 67 COVID-19 patients each. The prevalence of pneumothorax was determined. Multiple logistic regression was used to determine factors associated with pneumothorax. P value < 0.05 was taken as significant. Results: The prevalence of pneumothorax in COVID-19 patients was 1.6%. Lung disease, comorbidities, and oxygen support, which were significantly different between the two groups before PSM, were homogenized after PSM. In a univariate analysis, symptom duration (P 0.001), neutrophilia (P 0.001), lymphopenia (P 0.001), neutrophil-lymphocyte ratio (P = 0.003), ferritin levels (P = 0.012), D-dimer levels (P = 0.011), MV support (P 0.001), antibiotherapy (P 0.001), length of hospital stay (P = 0.009), and death (P = 0.002) differed significantly between the groups. Pneumothorax had a significant negative effect on survival (32.8% vs. 59.7%, P = 0.01). In a multivariate regression model, factors associated with pneumothorax were duration of symptoms (Adjusted Odds ratio (AOR) 1.68; 95% Confidence Interval (CI): 1.26-2.25; P = 0.001), mechanical ventilation (AOR 23.92; 95% CI: 4.12-138.72; P = <0.001), dual antibiotics (AOR 8.28; 95% CI: 1.56-43.86; P = 0.013), neutrophilia (AOR: 1.08; 95% CI: 1.02-1.14; P = 0.011), and lymphopenia (AOR: 0.92; 95% CI: 0.86-0.90; P = 0.022). Conclusion: The presence of pneumothorax was associated with poor survival in COVID-19 patients. Patients with a prolonged time from symptom onset to treatment and those dependent on mechanical ventilation in intensive care were in the high risk group for the development of pneumothorax. Copyright © 2024 Nigerian Journal of Clinical Practice.
URI: https://doi.org/10.4103/njcp.njcp_785_23
https://hdl.handle.net/20.500.14365/5535
ISSN: 1119-3077
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection

Show full item record



CORE Recommender

Page view(s)

34
checked on Nov 18, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.